Sanofi and Regeneron have reported new data for Libtayo that suggests the drug could be a contender. Overall survival (OS) was 22 months with the combination, compared to 13 months with chemo on ...

Key products like EYLEA, Libtayo, and Dupixent propelled the company’s growth. Dupixent continues to be a major success, treating over a million patients worldwide, and it may find new uses.

Libtayo was the sixth PD-L/PD-L1 inhibitor to reach the market, starting out as a therapy for another skin cancer called cutaneous squamous cell carcinoma (CSCC), and the rarity of that disease ...

Meghan Markle’s moment has arrived. The Duchess of Sussex officially released her As Ever products on her website Wednesday. The line features a $28 jar of wildflower honey, $15 flower sprinkles ...

From foodservice and retail to packaging and equipment, discover the latest seafood products available to support your business or offer to your end customer with the SeafoodSource Product Showcase.

DiveWire guarantees visibility for your news announcements through instant distribution to BioPharma Dive’s audience and its 176,000 newsletter subscribers for 21 days.